Alnaparin 40mg Injection


Product introduction
Alnaparin 40mg Injection is administered under the skin by a doctor or nurse. It should not be injected into a muscle. The dose and duration of the treatment are based on your medical condition, your response to the medicine, and what you are being treated for. While on treatment with this medicine, avoid activities that increase your risk of bleeding or injury.
Common side effects of this medicine include injection site pain, bleeding, headache, increased blood platelets, breathing problems, edema, anemia, fever, diarrhea, and increased liver enzymes. A severe headache could be a sign of bleeding in the brain. A severe stomach ache could be a sign of bleeding in the stomach. Bleeding can be dangerous and may not be obvious. Look out for symptoms and tell your doctor if you are worried.
Before receiving this medicine, let your doctor know if you have high blood pressure, diabetes, or have had a recent stroke. You should not take it if you have any current bleeding. Some medicines should not be used with Alnaparin 40mg Injection. Let your doctor know about all the medicines you are taking to make sure it is safe. If you have low body weight, you may be at increased risk of bleeding, and drinking alcohol can increase the risk of stomach bleeding.
Uses of Alnaparin Prefilled Syringe
- Treatment of Deep vein thrombosis
- Pulmonary embolism
- Acute coronary syndrome
Benefits of Alnaparin Prefilled Syringe
In Treatment of Deep vein thrombosis
In Pulmonary embolism
In Acute coronary syndrome
Side effects of Alnaparin Prefilled Syringe
Common side effects of Alnaparin
- Anemia (low number of red blood cells)
- Edema (swelling)
- Diarrhea
- Low blood platelets
- Bleeding
- Headache
- Increased liver enzymes
- Fever
- Injection site pain
- Breathing problems
How to use Alnaparin Prefilled Syringe
How Alnaparin Prefilled Syringe works
Safety advice
Alnaparin 40mg Injection is released in small amounts in the breast milk and amounts reaching the baby are also small, which would not be expected to cause any harmful effects to the baby.
However, cautious use is advised in patients with underlying liver disease.
What if you forget to take Alnaparin Prefilled Syringe?
All substitutes
Quick tips
- You have been prescribed Alnaparin 40mg Injection for conditions associated with the treatment and prevention of blood clots.
- Alnaparin 40mg Injection increases your risk of bleeding. Be careful while shaving, using sharp objects, or cutting fingernails or toenails.
- Inform your doctor if you are also taking other medicines thatincrease the bleeding risk, like aspirin and NSAIDs.
- Inform your doctor if there is bleeding from gums, nose, or wounds that lasts more than 15 minutes or if blood appears in your urine, stool, or vomit.
Fact Box
Interaction with drugs
Patient concerns
FAQs
What is Alnaparin 40mg Injection used for?
How is Alnaparin 40mg Injection given?
For how long will I need to take Alnaparin 40mg Injection?
Who should use Alnaparin 40mg Injection with caution?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 373-74.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 471.
- Enoxaparin [Summary of Product Characteristics]. Amsterdam, Netherlands: Techdow Pharma Netherlands B.V. [Accessed 19 Jan. 2026]. (online) Available from: drive.google.com/file/d/1zjl3wTT8W_rbQyBScHSO0cQKsOtYGeWz/view








